|
Intervention
From: Health Sector
Reform in Asia and the Pacific – options for developing countries –
Asia Development Bank 1999 |
Prioritization Factors |
|
Cost/ DALY ($) |
Evidence of medical efficacy
|
Burden of disease |
Corrects market failure |
Improves equity |
|
Screening for easily treated/prevented cancers |
50-100 |
3 = Some prospective data; if discovered, treatment
moderately effective |
Moderate
|
No
|
No
|
|
Improvement in water supply, sanitation, and household
ventilation |
Unknown but likely to be high |
2 = Inferred from survey data
|
High
|
Yes
|
Yes
|
|
Vector control using chemical pesticides |
25-250
|
2 = Time series data; effectiveness likely |
Moderate
|
Yes
|
Yes
|
|
Treatment of leprosy |
25-75
|
4 = Clinical data
|
Moderate
to low |
No
|
Yes
|
|
Blood screening for HIV |
25-1,000
|
4 = Good data; effective if HIV prevalent |
Moderate
|
No
|
No
|
|
Treatment of schizophrenia, manic-depression, and
depression |
75-350
|
4 = Good data; effective therapy |
Moderate
|
No
|
No
|
|
Treatment of stable angina and diabetes |
25-250
|
4 = Good clinical data; moderate effectiveness 3 =
Prospective RCT; efficacy difficult to attain |
Moderate
to low
|
No
|
No
|
|
Cancer pain palliation |
150
|
4 = For pain relief |
Moderate/ High |
No |
Yes |
|
Rehabilitation from injuries, leprosy, and polio |
200-225 |
3 = Variable depending on condition |
High |
No |
Yes |
|
Treatment of injuries and minor trauma |
25-250 |
3 = Clinical efficacy excellent depending on type of
injury |
High |
No |
Yes |